CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

Clinical trial NCT05931276 · RECRUITING

Trial details

NCT number: NCT05931276
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

End-Stage Kidney Disease End-Stage Renal Disease

Start date: 2024-05-22
Primary completion: 2026-12-31
Enrollment: 2540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.